Certara to Participate in the Barclays Global Healthcare Conference

Certara (Nasdaq: CERT) announced its participation in the Barclays Global Healthcare Conference on March 15, 2023, at 11:15 AM ET.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

Certara (Nasdaq: CERT) announced its participation in the Barclays Global Healthcare Conference on March 15, 2023, at 11:15 AM ET. This event highlights the company's leadership in biosimulation technology aimed at transforming drug discovery and development. A live webcast will be hosted on Certara’s investor relations website, with a replay available for 90 days. Certara serves over 2,000 clients, including biopharmaceutical companies and regulatory agencies across 62 countries. The company continues to accelerate medicine development through its proprietary software and services.

Argus Session date unavailable

+0.83% session move Open Argus

Details

News Market Reaction – CERT

The recorded move for CERT in the trading session of this news was +0.83%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

02/27/2023 - 04:30 PM EST

PRINCETON, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the Barclays Global Healthcare Conference.

Company management will present at 11:15AM ET on Wednesday, March 15^th, 2023.

A live webcast of the event will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.

About Certara
Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions and regulatory agencies across 62 countries.

Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com

Media Contact:
Daniel Yunger
Kekst CNC
daniel.yunger@kekstcnc.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Certara present at the Barclays Global Healthcare Conference?

Certara will present at the Barclays Global Healthcare Conference on March 15, 2023, at 11:15 AM ET.

Where can I watch Certara's presentation at the Barclays Conference?

You can watch Certara's presentation live on their investor relations website.

How long will the webcast of Certara's presentation be available?

The webcast of Certara's presentation will be available for replay for at least 90 days.

What industry does Certara operate in?

Certara operates in the biosimulation industry, focusing on drug discovery and development.

How many clients does Certara serve?

Certara serves over 2,000 clients globally.

Keep reading

Trending in the feed

REVVF

Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario Open the live feed